Stock listing

Euronext:ALIKO Ikonisys SA Action

Home listing (Euronext) of Ikonisys SA

Follow Ikonisys SA into a list and get an email when it puts out news.

Share price · EURONEXT:ALIKO

€1.54 EUR +0.16 (+11.6%)

Close on Nov 20, 2026

Past year +10.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€1.47 – €1.54 EURNov 20, 2026
Volume
2,712 sharesNov 20, 2026
Market cap
€24.37M EURAt the close on Nov 20, 2026 · price × 15.83M shares outstanding
52-week range
€1.30 – €1.84 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€3,685 EURMedian day 1,784 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Ikonisys SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALIKO · Home€1.54 EUR+0.16 (+11.6%)2,712€1.47€1.54€1.47€1.38Close on Nov 20, 2026
Frankfurt:9W8€1.37 EUR+0.03 (+2.2%)—€1.37€1.37€1.37€1.34Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:ALIKO · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.54+0.16+11.6%€1.47€1.54€1.472,712
€1.38-0.07-4.8%€1.46€1.46€1.382,430
€1.45-0.01-0.7%€1.45€1.45€1.45957
€1.46+0.01+0.7%€1.44€1.46€1.416,143
€1.450.000.0%€1.45€1.45€1.391,613
€1.45+0.04+2.8%€1.40€1.45€1.402,754
€1.410.000.0%€1.41€1.41€1.415
€1.410.000.0%€1.41€1.42€1.39344
€1.41+0.01+0.7%€1.40€1.41€1.36410
€1.400.000.0%€1.40€1.40€1.406
€1.40-0.01-0.7%€1.40€1.40€1.406
€1.41+0.01+0.7%€1.39€1.41€1.3988
€1.40-0.01-0.7%€1.41€1.42€1.38637
€1.41-0.01-0.7%€1.42€1.42€1.41232
€1.42-0.01-0.7%€1.42€1.42€1.4244
€1.43+0.03+2.1%€1.40€1.45€1.403,334
€1.40+0.07+5.3%€1.35€1.41€1.351,947
€1.33-0.05-3.6%€1.36€1.36€1.336,542
€1.38+0.01+0.7%€1.37€1.39€1.362,521
€1.37-0.01-0.7%€1.37€1.37€1.37168
€1.38-0.03-2.1%€1.35€1.41€1.351,482
€1.410.000.0%€1.40€1.41€1.352,314
€1.41-0.02-1.4%€1.43€1.43€1.361,777
€1.430.000.0%€1.41€1.43€1.41349
€1.43+0.02+1.4%€1.43€1.43€1.4310
€1.410.000.0%€1.42€1.42€1.41190
€1.41-0.03-2.1%€1.42€1.42€1.41190
€1.44+0.02+1.4%€1.42€1.44€1.42303
€1.42+0.02+1.4%€1.42€1.42€1.42445
€1.40-0.04-2.8%€1.42€1.42€1.402,001
€1.44+0.01+0.7%€1.42€1.44€1.42305
€1.43-0.01-0.7%€1.43€1.43€1.431,010
€1.44-0.01-0.7%€1.44€1.45€1.434,177
€1.45-0.02-1.4%€1.46€1.46€1.443,288
€1.47+0.02+1.4%€1.44€1.47€1.4011,547
€1.45+0.05+3.6%€1.40€1.45€1.3513,490
€1.40-0.01-0.7%€1.41€1.41€1.403,136
€1.41-0.02-1.4%€1.42€1.42€1.412,689
€1.43+0.01+0.7%€1.42€1.43€1.42810
€1.420.000.0%€1.41€1.43€1.415,112
€1.42+0.01+0.7%€1.41€1.42€1.41569
€1.41-0.01-0.7%€1.41€1.41€1.41205
€1.420.000.0%€1.41€1.42€1.411,079
€1.42+0.04+2.9%€1.40€1.42€1.405,931
€1.38-0.02-1.4%€1.39€1.39€1.381,791
€1.400.000.0%€1.39€1.40€1.382,144
€1.400.000.0%€1.39€1.40€1.391,401
€1.400.000.0%€1.40€1.40€1.309,339
€1.400.000.0%€1.36€1.40€1.364,685
€1.400.000.0%€1.36€1.40€1.364,685
€1.400.000.0%€1.38€1.40€1.342,690
€1.400.000.0%€1.42€1.42€1.40244
€1.40-0.02-1.4%€1.42€1.42€1.40244
€1.42+0.02+1.4%€1.42€1.42€1.422,500
€1.40-0.02-1.4%€1.40€1.40€1.405,201
€1.420.000.0%€1.42€1.42€1.418,028
€1.42-0.06-4.1%€1.48€1.48€1.409,005
€1.48-0.04-2.6%€1.50€1.50€1.48347
€1.52+0.06+4.1%€1.46€1.52€1.464,595
€1.46-0.02-1.4%€1.46€1.46€1.46377
€1.48+0.02+1.4%€1.46€1.48€1.46514
€1.46+0.04+2.8%€1.42€1.46€1.422,737
€1.42-0.04-2.7%€1.44€1.44€1.404,735
€1.46-0.08-5.2%€1.52€1.52€1.424,146
€1.54+0.02+1.3%€1.54€1.54€1.52278
€1.520.000.0%€1.54€1.54€1.505,217
Ticker
Euronext:ALIKO
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

All Ikonisys SA news

Ikonisys SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
22 in the last 12 months · 30 in all · newest Nov 12, 2026 · oldest 2025

Where Ikonisys SA is listed

ListingExchangeCountryCurrency
Euronext:ALIKO · Home listing · This pageEuronextFranceEUR
LS Exchange:A3CVR6LS ExchangeGermanyEUR
Frankfurt:9W8FrankfurtGermanyEUR
Lang & Schwarz:A3CVR6Lang & SchwarzGermanyEUR
Stuttgart:9W8StuttgartGermanyEUR

Valuation

EV/sales 20.4× against a median of 1.8×: 8th lowest of 9 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€28.35M EUR
P/E
Loss
EV/sales
20.4×
EV/EBITDA
Negative EBITDA
Price/book
1.3×
Gross margin
64.6%
Operating margin
−290.7%
Net margin
−302.8%
Debt to equity
0.3×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Ikonisys SA · EURONEXT:ALIKOUS$26.75MUS$31.11Mn/a20.4×n/a1.3×−302.8%0.3×n/a
Abingdon Health PLC · LSE:ABDXUS$28.12MUS$26.13Mn/a1.8×n/a3.5×−19.4%0.2×n/a
MedMira Inc. · TSXV:MIRUS$26.91MUS$27.23Mn/a105×n/an/a−808.2%n/a0.29
BIOQUAL, Inc. · OTC:BIOQUS$26.83MUS$42.28Mn/a1.1×n/a0.8×−11.0%1.0×-0.01
Interpace Biosciences, Inc. · OTC:IDXGUS$26.56MUS$23.63M1.2×0.6×21.0×1.1×58.1%0.0×-0.33
Microbix Biosystems Inc. · TSX:MBXUS$26.27MUS$25.96Mn/a2.4×n/a1.6×−31.7%0.3×0.03
Bioptic Inc. · TPEX:6850US$26.11MUS$22.56Mn/an/an/a2.0×n/a0.2×n/a
genOway SA · EURONEXT:ALGENUS$25.87MUS$38.95M25.4×1.7×8.7×1.1×4.4%0.7×n/a
Orientbio, Inc. · KRX:002630US$25.03M−US$3.27M14.6×−0.1×−0.8×0.5×8.1%0.0×n/a
Clever Culture Systems Limited · ASX:CC5US$24.62MUS$25.47Mn/a8.3×n/a4.9×−48.4%0.4×n/a
CLEO Diagnostics Ltd · ASX:COVUS$24.57MUS$20.44Mn/an/an/a7.4×n/a0.0×n/a
Median of the othersUS$26.19MUS$25.72M14.6×1.8×8.7×1.6×−15.2%0.2×0.01

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
2.30 EUR · Analysts' mean
EPS, year to Dec 2026
0.030 · 1 analyst
Revenue, year to Dec 2026
2M · 1 analyst

Team and board

OfficerRole
Francesco TrisoliniGroup CEO and for implementation of the approved industrial plan

Events

QuarterResultsShare move
Quarter to Sep 30, 2025Nov 3, 20250.0%
Q2 2025Sep 24, 20250.0%
Quarter to Sep 30, 2024Nov 7, 2024−4.0%
Q3 2022Oct 27, 2022 · After close−1.2%
Q1 2022Apr 29, 2022 · After close−0.4%
Q3 2021Oct 29, 2021 · After close+5.5%
Q2 2021Jul 1, 2021

Open Events

Financings

RaiseDateIn US dollars
Convertible notes
Closed: €722,500 raised
Use of proceeds: Strengthen the Group's available liquidity
Aug 24, 2026US$842,864
Private placement of new ordinary shares
Closed: €1.5M raised · €1.5 a share
Buyers: Avantgarde Srl; Alberto Previtali
Use of proceeds: Mainly commercial development and expanding the distributor network; also technology and product development, and regulatory and certification work
Dec 19, 2025US$1.76M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue1.39M1.01M448.6K935.2K365.1K99.8K68.4K
Cost of revenue490.8K295.7K192.7K183.4K70.6K27.1K63.7K
Gross profit897.3K715.4K255.8K751.8K28.5K72.8K4.75K
Research and development418.1K680.0K1.38M45.2K37.9K
Selling, general and administrative1.35M1.71M770.5K645.7K874.2K9.52K15.6K
Operating income-4.04M-3.05M-2.19M-2.64M-564.2K204.7K-250.9K
Depreciation and amortization2.76M1.28M1.27M1.08M80.6K68.2K70.8K
EBITDA-1.28M-1.77M-927.4K-1.55M-483.7K272.9K-180.0K
Interest expense304.0K186.3K73.9K13.5K5.11K1.77M1.62M
Income before tax-4.20M-3.24M-2.27M-2.45M-569.3K-1.57M-1.87M
Income tax2.38K2.90K-257.7K1.93K6.30K5.05K
Net income-4.20M-3.24M-2.27M-2.45M-571.3K-1.57M-1.88M
Earnings per share, basic-0.30-0.29-0.22-0.26-0.06-0.16-0.19

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents1.03M25.1K9.40K94.0K1.52M37.6K173.0K
Short-term investments2.24K35.8K46.8K
Receivables899.8K651.0K3.21K24.6K139.1K29.5K28.8K
Inventory730.0K688.6K473.4K446.3K141.6K
Current assets2.66M1.66M691.1K693.1K1.88M70.7K208.8K
Property, plant and equipment10.0K301.1K70
Goodwill22.0M22.0M16.1M16.1M16.1M4.42M4.82M
Total assets26.7M27.4M20.9M21.7M22.5M8.08M8.13M
Accounts payable1.84M1.74M1.29M1.08M977.5K812.8K760.8K
Current liabilities5.55M3.01M2.30M1.51M1.24M2.19M1.76M
Long-term debt1.32M4.02M3.21M2.21M1.20M119.5K130.5K
Total debt3.25M4.13M3.40M2.51M1.24M198.4K296.7K
Total liabilities7.58M13.1M5.12M4.04M2.50M2.39M2.04M
Shareholders' equity19.1M14.3M15.7M17.7M20.0M5.70M6.09M
Shares outstanding13.9M11.2M10.5M9.48M9.48M9.71M9.71M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-1.16M-1.33M-914.2K-1.14M-781.4K-1.52M
Capital spending-9.09K-37.9K-542.4K-874.7K-576.0K00
Free cash flow-1.17M-1.37M-1.46M-2.01M-1.36M-1.52M
Cash from investing-301.6K-67.6K-545.2K-884.2K-636.6K-239.6K
Cash from financing2.36M1.41M1.37M599.1K2.90M1.62M
Share buybacks469.5K3.03M-170.7K
Change in cash1.00M15.7K-84.6K-1.42M1.48M-135.4K

Open Financials

Filings

Open Filings

Cap table

Built by 6ix from Ikonisys SA’s releases · as of Aug 24, 2026

Common shares
15,825,785
Fully diluted
15,825,785

Fully diluted

LineShares
Common shares15,825,785

Share count over time

CountShares
Nov 22, 202615,825,785

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Francesco TrisoliniGroup CEO and for implementation of the approved industrial plan · Since at least Feb 17, 2026

Open People

Log in to ask 6ix AI your own questions about Ikonisys SA.